ABBOT STEWART 4
4 · FATE THERAPEUTICS INC · Filed May 16, 2018
Insider Transaction Report
Form 4
ABBOT STEWART
Chief Development Officer
Transactions
- Exercise/Conversion
Common Stock
2018-05-15$6.90/sh+18,138$125,152→ 64,917 total - Exercise/Conversion
Stock Option (right to buy)
2018-05-15−2,916→ 67,084 totalExercise: $4.89Exp: 2025-10-15→ Common Stock (2,916 underlying) - Exercise/Conversion
Stock Option (right to buy)
2018-05-15−18,138→ 51,862 totalExercise: $6.90Exp: 2025-08-03→ Common Stock (18,138 underlying) - Exercise/Conversion
Common Stock
2018-05-15$4.89/sh+2,916$14,259→ 46,779 total
Footnotes (3)
- [F1]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on November 12, 2015, such that this option is fully exercisable on October 12, 2019, subject to the recipient's continued service relationship with the Issuer. This option is subject to an accelerated vesting upon a change of control of the Issuer and in the event of termination of employment under certain circumstances following a change of control of the Issuer.
- [F2]Not applicable.
- [F3]The shares subject to the option shall vest and become exercisable at the rate of 1/4th of the shares on July 13, 2016 and 1/48th of the shares each month thereafter such that this option is fully exercisable on July 13, 2019. This option is subject to an accelerated vesting upon a change of control of the Issuer and in the event of termination of employment under certain circumstances following a change of control of the Issuer.